IV Lidocaine Infusion for Neuropathic Pain

Brief summary (from the registry)

The investigators will conduct a retrospective cohort study of patients who have undergone i.v. lidocaine infusions in the previous 2 years for suspected neuropathic pain of heterogeneous origin. The investigators hypothesize that the analgesic response to intravenous (i.v.) lidocaine will be bimodal with clear responders and clear non-responders. The investigators also hypothesize that more refractory patients, who have failed previous multimodal analgesic therapy, will be less likely to respond to i.v. lidocaine. The investigators goals are to report what percentage of patients will achieve relief, the degree of relief that can be expected, and identify the type of patients who will most likely to benefit from systemic lidocaine. The investigators secondary objective is to report the correlation between infusion rates and patterns of infusion rate adjustments with regard to efficacy and adverse effects.

Study details

Official title

A Retrospective Analysis of Clinical Outcomes of IV Lidocaine Infusion for Neuropathic Pain: Assessing Predictors of Clinically Relevant Analgesia and to Report the Efficacy and Side Effect Profile of Infusion

Conditions

• Neuropathic Pain
• Complex Regional Pain Syndrome
• Chronic Pain

Sponsor

Henry Ford Health System

Start date

2016-04

Primary completion

2023-01

Sex

All

Age range

from 18 Years

Healthy volunteers

true

Results posted

No results posted in this snapshot

Countries

United States

Total sites listed

1

Eligibility criteria